Disclosure Insight Maintains Medium Risk Rating on Humana

A report from Disclosure Insight reiterates its Medium Risk rating on Humana

. The D.I. HUM profile states, “Concentrated revenue; acquisition activity; an ongoing internal investigation; and the chairman and CEO positions being held by one person support our opinion of a Medium Risk - Negative Bias rating on HUM. Contracts with the federal government accounted for approximately 75% and 64% of total revenue in 2010 and 1H11, respectively. HUM reported 9 acquisitions for approximately $2 billion, of which at least $1.2 billion was allocated to goodwill." HUM closed yesterday at $74.22.